ADVERUM BIOTECHNOLOGIES INC's ticker is and the CUSIP is 00773U908. A total of 2 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102 | +191.4% | 68,600 | +207.6% | 0.00% | – |
Q2 2023 | $35 | +1066.7% | 22,300 | -14.6% | 0.00% | – |
Q1 2023 | $3 | -97.8% | 26,100 | -89.1% | 0.00% | – |
Q4 2022 | $138 | -99.9% | 238,500 | 0.0% | 0.00% | – |
Q3 2022 | $226,000 | -48.5% | 238,500 | -34.9% | 0.00% | – |
Q2 2022 | $439,000 | -27.7% | 366,500 | -20.9% | 0.00% | -100.0% |
Q1 2022 | $607,000 | -41.5% | 463,500 | -21.3% | 0.00% | 0.0% |
Q4 2021 | $1,037,000 | +421.1% | 589,300 | +963.7% | 0.00% | – |
Q3 2021 | $199,000 | +15.0% | 55,400 | +11.5% | 0.00% | – |
Q2 2021 | $173,000 | +220.4% | 49,700 | +90263.6% | 0.00% | – |
Q1 2021 | $54,000 | -44.3% | 55 | -38.9% | 0.00% | – |
Q4 2020 | $97,000 | +47.0% | 90 | +38.5% | 0.00% | – |
Q3 2020 | $66,000 | -73.0% | 65 | -44.4% | 0.00% | – |
Q2 2020 | $244,000 | +180.5% | 117 | +30.0% | 0.00% | – |
Q1 2020 | $87,000 | -85.2% | 90 | -82.4% | 0.00% | -100.0% |
Q4 2019 | $589,000 | +40.6% | 512 | -33.4% | 0.00% | 0.0% |
Q3 2019 | $419,000 | +5885.7% | 769 | +12716.7% | 0.00% | – |
Q2 2019 | $7,000 | 0.0% | 6 | -60.0% | 0.00% | – |
Q1 2019 | $7,000 | -41.7% | 15 | -63.4% | 0.00% | – |
Q4 2018 | $12,000 | -69.2% | 41 | -37.9% | 0.00% | – |
Q3 2018 | $39,000 | +457.1% | 66 | +371.4% | 0.00% | – |
Q2 2018 | $7,000 | +16.7% | 14 | -97.0% | 0.00% | – |
Q1 2018 | $6,000 | – | 471 | +47000.0% | 0.00% | – |
Q4 2017 | $0 | – | 1 | -50.0% | 0.00% | – |
Q3 2017 | $0 | – | 2 | -90.5% | 0.00% | – |
Q3 2016 | $0 | – | 21 | +2000.0% | 0.00% | – |
Q2 2016 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 26,100 | $3 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |